Motilal Oswal has given Gland Pharma a ‘Buy’ rating with a Rs 2,310 target price, implying a 17% upside. The…
Pine Labs IPO opens Nov 7-11; ESOP costs surge to Rs 180 crore. Review key investment details and subscribe now!
GIFT Nifty opens higher; track global markets, gold, and sectoral trends to stay updated on today’s key market cues.
Groww IPO GMP Highlights, Groww IPO Subscription Status Day 3 Highlights: Groww IPO closes bids on Nov 7 with a…
Track earnings movers from Sun Pharma to Paytm as Indian markets close lower; see which stocks to watch today!
Check your Lenskart IPO allotment status online as finalisation is set for November 6 and refunds begin from November 7.…
Orkla India’s debut on BSE and NSE on November 06: ; IPO listed at 3% premium, but closes 5.5% lower…
NSE sets aside Rs 1,297 crore for SEBI settlement and sees a 12% drop in transaction revenues. Explore full Q2FY26…
Morgan Stanley sees India’s bull cycle regaining strength with the Sensex potentially hitting 1,00,000 by June 2026 on solid earnings…
Mahindra & Mahindra stock set for up to 21% upside as brokerages see strong growth; check targets and key drivers…
Motilal Oswal has given a ‘Buy’ rating to Tata Consumer Products with a target price of Rs 1,450, implying a…
Axis Securities expects India’s rebound to extend through FY26, driven by GDP growth of 6.8% and steady liquidity. The brokerage…
The stock market is closed today, November 5, for Guru Nanak Jayanti. Both BSE and NSE will remain shut across…
Global brokerage Jefferies has turned bullish on select domestic stocks, reaffirming Buy calls on Shriram Finance, HDB Financial, Aditya Birla…
Markets today at close, November 04: Sensex drops over 500 points, Nifty slips below 25,600; see which stocks moved and…
Global brokerage Bernstein has turned bullish on Swiggy and Eternal (Zomato), calling them the key winners in India’s ₹6.7 lakh…
Motilal Oswal recommends Ambuja Cements, Blue Dart Express, and Niva Bupa Health Insurance for up to 28% returns— check their…
BEL shares upgraded with a new target of Rs 470 despite a downgrade—see if now is the time to invest!